President Rodrigo Duterte signed an executive decree (EO) that would regulate the prices of drugs and drugs used to fight the main causes of morbidity in the country, MalacaÃ±ang announced Wednesday.
Acting palace spokesman Karlo Alexei Nograles said the president signed EO 155 on Tuesday, December 7, 2021.
“This is part of the efforts to improve access to affordable and quality medicines and to reduce the health expenditure of our compatriots, in line with the objectives of the Universal Health Care Act,” Nograles said in a statement. .
The show states that price regulation via maximum retail price (MRP) and / or maximum wholesale price (MW) will be imposed on 34 drug molecules and 71 drug formulas used in agents affecting bone metabolism, pain relievers , anesthetics, antianginal drugs, antiarrhythmics, drugs against asthma and chronic obstructive pulmonary disease, antibiotics, anticoagulants, anticonvulsants, antidiabetic drugs, antidiuretics and antiemetics.
Also covered by EO are drug molecules and formulas used in anti-glaucoma, anti-hypercholesterolemic, antihypertensive, antineoplastic / anticancer drugs, antiparkinson drugs, drugs for overactive bladder, growth hormone inhibitors, immunosuppressants, chelators. iron. medicines for psoriasis, seborrhea and ichthyosis.